A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer

被引:93
作者
Wang, Lin [1 ]
Zhu, Miao-Jun [2 ]
Ren, Ai-Min [1 ]
Wu, Hong-Fei [2 ]
Han, Wu-Mei [2 ]
Tan, Ruo-Ying [2 ]
Tu, Rui-Qin [1 ]
机构
[1] Fudan Univ, Shanghai Zhongshan Hosp, Dept Obstet & Gynecol, Shanghai 200433, Peoples R China
[2] Biovue Technol China Ltd, Shanghai, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 05期
关键词
PATHOGENESIS; STATISTICS; INVASION;
D O I
10.1371/journal.pone.0096472
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epithelial ovarian cancer (EOC) is the most common gynecologic malignancy. To identify the micro-ribonucleic acids (miRNAs) expression profile in EOC tissues that may serve as a novel diagnostic biomarker for EOC detection, the expression of 1722 miRNAs from 15 normal ovarian tissue samples and 48 ovarian cancer samples was profiled by using a quantitative real-time polymerase chain reaction (qRT-PCR) assay. A ten-microRNA signature (hsa-miR-1271-5p, hsa-miR-574-3p, hsa-miR-182-5p, hsa-miR-183-5p, hsa-miR-96-5p, hsa-miR-15b-5p, hsa-miR-182-3p, hsa-miR-141-5p, hsa-miR-130b-5p, and hsa-miR-135b-3p) was identified to be able to distinguish human ovarian cancer tissues from normal tissues with 97% sensitivity and 92% specificity. Two miRNA clusters of miR183-96-183 (miR-96-5p, and miR-182, miR183) and miR200 (miR-141-5p, miR200a, b, c and miR429) are significantly up-regulated in ovarian cancer tissue samples compared to those of normal tissue samples, suggesting theses miRNAs may be involved in ovarian cancer development.
引用
收藏
页数:8
相关论文
共 27 条
  • [1] Natural history and prognosis of untreated stage I epithelial ovarian carcinoma
    Ahmed, FY
    Wiltshaw, E
    AHern, RP
    Nicol, B
    Shepherd, J
    Blake, P
    Fisher, C
    Gore, ME
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2968 - 2975
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] Patterns and progress in ovarian cancer over 14 years
    Chan, John K.
    Cheung, Michael K.
    Husain, Amreen
    Teng, Nelson N.
    West, Dee
    Whittemore, Alice S.
    Berek, Jonathan S.
    Osann, Kathryn
    [J]. OBSTETRICS AND GYNECOLOGY, 2006, 108 (03) : 521 - 528
  • [4] The case for early detection
    Etzioni, R
    Urban, N
    Ramsey, S
    McIntosh, M
    Schwartz, S
    Reid, B
    Radich, J
    Anderson, G
    Hartwell, L
    [J]. NATURE REVIEWS CANCER, 2003, 3 (04) : 243 - 252
  • [5] Gloss BS, 2012, CANC LETT
  • [6] A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
    Hu, Xiaoxia
    Macdonald, Dusten M.
    Huettner, Phyllis C.
    Feng, Zhihui
    El Naqa, Issam M.
    Schwarz, Julie K.
    Mutch, David G.
    Grigsby, Perry W.
    Powell, Simon N.
    Wang, Xiaowei
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (03) : 457 - 464
  • [7] Biological functions of MicroRNAs
    Huang, Yong
    Shen, Xing Jia
    Zou, Quan
    Zhao, Qiao Ling
    [J]. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2010, 36 (06) : 684 - 689
  • [8] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [9] Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
    Kan, Casina W. S.
    Hahn, Michael A.
    Gard, Gregory B.
    Maidens, Jayne
    Huh, Jung Yoon
    Marsh, Deborah J.
    Howell, Viive M.
    [J]. BMC CANCER, 2012, 12
  • [10] Kuhlmann JD, 2012, CLIN CHEM LAB MED, V50, P601, DOI 10.1515/cclm-2011-0847